i3 Health

Von Hippel-Lindau disease (VHL) is an inherited disorder that predisposes individuals to specific types of benign tumors, malignant tumors, and cysts in multiple organs, requiring the involvement of genetic counselors and clinicians across the interprofessional team for optimal management.In this webinar, gain expert perspectives from Dr. Eric Jonasch, Professor in the Department of Genitourinary Medical Oncology at the University of Texas MD Anderson Cancer Center, on the following: Varying clinical manifestations of VHL-associated tumors across organ systemsGenetic testing techniques for VHL, including benefits and limitationsEmerging therapies for VHL-associated tumors, including the FDA approval of belzutifanStrategies for conveying genetic information to patients and family membersMultisystemic management of VHL across the interprofessional teamAnd much more! Speaker: Eric Jonasch, MD (Professor, Department of Genitourinary Medical Oncology·University of Texas MD Anderson Cancer Center).